Women's opinions on the offer and use of nuchal translucency screening for Down syndrome

Prenatal Diagnosis

Volumn 26, Issue 2, 2006, Pages 105-111

  Müller, Moira A ^a   Bleker, Otto P ^a   Bonsel, Gouke J ^a   Bilardo, Caterina M ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Down syndrome; Nuchal translucency screening; Opinion survey; Ultrasound

Indexed keywords

ADULT; AGED; ARTICLE; ATTITUDE TO HEALTH; COHORT ANALYSIS; DOWN SYNDROME; FEMALE; FIRST TRIMESTER PREGNANCY; FREEDOM; HUMAN; MAJOR CLINICAL STUDY; MEDICAL PRACTICE; MIDWIFE; NUCHAL TRANSLUCENCY MEASUREMENT; PRENATAL CARE; PRIORITY JOURNAL; QUESTIONNAIRE; SCREENING TEST;

ADULT; ATTITUDE TO HEALTH; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; DOWN SYNDROME; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MASS SCREENING; NETHERLANDS; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; QUESTIONNAIRES;

EID: 33344469156     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/pd.1344     Document Type: Article

References (31)

1. Bennett MJ, Gau GS, Gau DW. 1980. Women's attitudes to screening for neural tube defects. Br J Obstet Gynaecol 87(5): 370-371.
2. Berne-Fromell K, Kjessler B. 1984. Anxiety concerning fetal malformations in pregnant women exposed or not exposed to an antenatal serum alpha-fetoprotein screening program. Gynecol Obstet Invest 17(1): 36-39.
3. Berne-Fromell K, Josefson G, Kjessler B. 1984. Who declines from antenatal serum alpha-fetoprotein screening-and why? Acta Obstet Gynecol Scand 63(8): 687-691.
4. Bossuyt PM, Raaymakers TWM, Bonsel GJ, Rinkel GJE. 2005. Screening families for intracranial aneurysms: anxiety, perceived risks and informed choice. Prev Med 41: 795-799.
5. Cicero S, Curcio P, Papageorghiou A, Sonek J, Nicolaides K. 2001. Absence of nasal bone in fetuses with trisomy 21 at 11-14 weeks of gestation: an observational study. Lancet 358(9294): 1665-1667.
6. Cuckle H. 1996. Established markers in second trimester maternal serum. Early Hum Dev 47(Suppl 1): S27-S29.
7. De Graaf IM, Pajkrt E, Bilardo CM, et al. 1999. Early pregnancy screening for fetal aneuploidy with serum markers and nuchal translucency. Prenat Diagn 19(5): 458-462.
8. Dormandy E, Hooper R, Michie S, Marteau TM. 2002. Informed choice to undergo prenatal screening: a comparison of two hospitals conducting testing either as part of a routine visit or requiring a separate visit. J Med Screen 9(3): 109-114.
9. Evers-Kiebooms G, Denayer L, van den BH. 1993. Community attitudes towards prenatal testing for congenital handicap. J Reprod Infant Psychol 11(1): 21-30.
10. Gezondheidsraad. 2004. Prenatale screening (2); Down syndroom, neuralebuisdefecten. Gezondheidsraad, editor. 2004/06. Den Haag.
11. Green JM, Hewison J, Bekker HL, Bryant LD, Cuckle HS. 2004. Psychosocial aspects of genetic screening of pregnant women and newborns: a systematic review. Health Technol Assess 8(33): iii, ix-x, 1-109.
12. Heikkila A, Ryynanen M, Kirkinen P, Saarikoski S. 1997. Results and views of women in population-wide pregnancy screening for trisomy 21 in east Finland. Fetal Diagn Ther 12(2): 93-96.
13. Jorgensen FS. 1995a. Attitudes to prenatal screening, diagnosis and research among pregnant women who accept or decline an alpha-fetoprotein test. Prenat Diagn 15(5): 419-429.
14. Jorgensen FS. 1995b. Declining an alpha-fetoprotein test in pregnancy, why and who? Acta Obstet Gynecol Scand 74(1): 3-11.
15. Kornman LH, Wortelboer MJ, Beekhuis JR, Morssink LP, Mantingh A. 1997. Women's opinions and the implications of first-versus second-trimester screening for fetal Down syndrome. Prenat Diagn 17(11): 1011-1018.
16. Marteau TM, Dormandy E, Michie S. 2001. A measure of informed choice. Health Expect 4(2): 99-108.
17. Mutton D, Ide RG, Alberman E. 1998. Trends in prenatal screening for and diagnosis of Down syndrome: England and Wales, 1989-1997. BMJ 317(7163): 922-923.
18. National Perinatal Database of the Netherlands. 2001.
19. Press N, Browner CH. 1997. Why women say yes to prenatal diagnosis. Soc Sci Med 45(7): 979-989.
20. Roelofsen EE, Kamerbeek LI, Tymstra TJ, Beekhuis JR, Mantingh A. 1993. Women's opinions on the offer and use of maternal serum screening. Prenat Diagn 13(8): 741-747.
21. Salonen R, Kurki L, Lappalainen M. 1996. Experiences of mothers participating in maternal serum screening for Down syndrome. Eur J Hum Genet 4(2): 113-119.
22. Santalahti P, Aro AR, Hemminki E, Helenius H, Ryynanen M. 1998. On what grounds do women participate in prenatal screening? Prenat Diagn 18(2): 153-165.
23. Sanden ML, Bjurulf P. 1988. Pregnant women's attitudes for accepting or declining a serum-alpha-fetoprotein test. Scand J Soc Med 16(4): 265-271.
24. Snijders RJ, Noble P, Sebire N, Souka A, Nicolaides KH. 1998. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group [see comments]. Lancet 352(9125): 343-346.
25. Spencer K, Souter V, Tul N, Snijders R, Nicolaides KH. 1999. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol 13(4): 231-237.
26. Tymstra T. 1989. The imperative character of medical technology and the meaning of "anticipated decision regret". Int J Technol Assess Health Care 5(2): 207-213.
27. Tymstra TJ, Bajema C, Beekhuis JR, Mantingh A. 1991. Women's opinions on the offer and use of prenatal diagnosis. Prenat Diagn 11(12): 893-898.
28. van den Berg M, Timmermans DR, Kleinveld JH, Garcia E, Van Vugt JM, van der WG. 2005. Accepting or declining the offer of prenatal screening for congenital defects: test uptake and women's reasons. Prenat Diagn 25(1): 84-90.
29. Wapner R, Thom E, Simpson JL, et al. 2003. First-trimester screening for trisomies 21 and 18. N Engl J Med 349(15): 1405-1413.
30. Wermer MJ, van der Schaaf I, Van Nunen P, Bossuyt PM, Anderson CS, Rinkel GJ. 2005. Psychosocial impact of screening for intracranial aneurysms in relatives with familial subarachnoid hemorrhage. Stroke 36(4): 836-840.
31. Weinans MJ, Huijssoon AM, Tymstra T, Gerrits MC, Beekhuis JR, Mantingh A. 2000. How women deal with the results of serum screening for Down syndrome in the second trimester of pregnancy. Prenat Diagn 20(9): 705-708.